Bernadett Szabados

ctDNA guiding adjuvant immunotherapy in urothelial carcinoma

Thomas Powles, Zoe J. Assaf, Nicole N. Davarpanah et al. · Nature · 2021 · 578 citations

Adjuvant Immunotherapy, Cancer Immunosurveillance, Urology +1

Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial

Thomas Powles, Mark Kockx, Alejo Rodríguez‐Vida et al. · Nature Medicine · 2019 · 555 citations · Full text

Urology, Biomarker Analysis, Genitourinary Cancer +7

Bladder cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

Tom Powles, Joaquim Bellmunt, Éva Compérat et al. · Annals of Oncology · 2021 · 492 citations · Full text

Urology, Surgical Oncology, Genitourinary Cancer +5

Final Results of Neoadjuvant Atezolizumab in Cisplatin-ineligible Patients with Muscle-invasive Urothelial Cancer of the Bladder

Bernadett Szabados, Mark Kockx, Zoe J. Assaf et al. · European Urology · 2022 · 175 citations

Urology, Genitourinary Cancer, Muscle-invasive Urothelial Cancer +7

ESMO Clinical Practice Guideline interim update on first-line therapy in advanced urothelial carcinoma

Thomas Powles, Joaquim Bellmunt, Éva Compérat et al. · Annals of Oncology · 2024 · 135 citations · Full text

First-line Therapy, Surgical Oncology, Urology +7